Revolutionary Parkinson’s Treatment at King’s College Hospital Dubai
In a groundbreaking development, King’s College Hospital London in Dubai has brought new hope to Parkinson’s patients by successfully performing subcutaneous levodopa (fos-levodopa) pump therapy on the youngest Parkinson’s patient in the UAE and the MENA region.
A Breakthrough in Parkinson’s Care
At the tender age of 30, the patient was diagnosed with Parkinson’s disease and had been dependent on three caregivers for 14 years. This cutting-edge treatment offers a ray of hope for Parkinson’s patients, providing potential improvements to their quality of life.
The introduction of Foslevodopa pump therapy in the Middle East by King’s College Hospital Dubai has been a game-changer. The continuous delivery of levodopa through the skin via this pump, similar to an insulin pump for diabetes, allows for personalized dosing tailored to each patient’s needs. Specialists like Dr. Vinod Metta and Prof. Ray Chaudhuri ensure that the therapy is customized to suit the patient’s condition. With this innovative pump, patients can reclaim some independence and perform daily tasks, including fasting during Ramadan, that were previously challenging due to their condition.
“Personalized care and individualized dosing are crucial in Parkinson’s treatment,” stated Dr. Vinod Metta, Consultant Interventional Neurologist and Parkinson’s Specialist at King’s College Hospital London in Dubai. “With the Foslevodopa pump, patients can regain control, independence, and enhance their quality of life.”
The procedure took place at the Parkinson’s Center of Excellence in King’s College Hospital Dubai, a regional hub for movement disorders. The center offers top-notch diagnostic and treatment innovations, along with multidisciplinary support for patients and their families, ensuring patient-centric care.
Prof. Ray Chaudhuri, a renowned expert in neurology and movement disorders at King’s College Hospital London, emphasized the significance of this milestone, stating, “This marks a pivotal moment in Parkinson’s care in the region. Foslevodopa represents a significant advancement in personalized therapy, providing patients with optimal care.”
Leading the Future of Parkinson’s Care
King’s Parkinson’s Centre of Excellence in Dubai, spearheaded by UK-trained specialists like Dr. Vinod Metta and Prof. Ray Chaudhuri, offers personalized treatment plans supported by a multidisciplinary team comprising various healthcare professionals. Since its inception under Dr. Metta’s leadership, the center has served over 1,000 Parkinson’s patients across the Gulf Cooperation Council countries.
For more information about the foslevodopa/foscarbidopa pump treatment, reach out to King’s Parkinson’s Centre of Excellence:
-
Ms. Therese Masagnay: Therese.Masagnay@kch.ae
-
Ms. Clarissa Sanglian: Clarissa.Sanglian@kch.ae
-
Research Studies & Clinical Trials Coordinator: Afsal.Nalarakettil@kch.ae
This breakthrough treatment offers a beacon of hope for Parkinson’s patients in the UAE and beyond.
